68 related articles for article (PubMed ID: 30464390)
1. Molecular Modification of Metadherin/MTDH Impacts the Sensitivity of Breast Cancer to Doxorubicin.
Song Z; Wang Y; Li C; Zhang D; Wang X
PLoS One; 2015; 10(5):e0127599. PubMed ID: 25993398
[TBL] [Abstract][Full Text] [Related]
2. Identification of a potent herbal molecule for the treatment of breast cancer.
Koduru S; Sowmyalakshmi S; Kumar R; Gomathinayagam R; Rohr J; Damodaran C
BMC Cancer; 2009 Jan; 9():41. PubMed ID: 19183448
[TBL] [Abstract][Full Text] [Related]
3. Intracellular Delivery of Stabilized Peptide Blocking MTDH-SND1 Interaction for Breast Cancer Suppression.
Chen H; Zhan M; Zhang Y; Liu J; Wang R; An Y; Gao Z; Jiang L; Xing Y; Kang Y; Li Z; Yin F
JACS Au; 2024 Jan; 4(1):139-149. PubMed ID: 38274259
[TBL] [Abstract][Full Text] [Related]
4. Lobaplatin induces pyroptosis through regulating cIAP1/2, Ripoptosome and ROS in nasopharyngeal carcinoma.
Chen Z; Xu G; Wu D; Wu S; Gong L; Li Z; Luo G; Hu J; Chen J; Huang X; Chen C; Jiang Z; Li X
Biochem Pharmacol; 2020 Jul; 177():114023. PubMed ID: 32413426
[TBL] [Abstract][Full Text] [Related]
5. FBXW7 in breast cancer: mechanism of action and therapeutic potential.
Chen S; Leng P; Guo J; Zhou H
J Exp Clin Cancer Res; 2023 Sep; 42(1):226. PubMed ID: 37658431
[TBL] [Abstract][Full Text] [Related]
6. Identification of miRNA biomarkers for breast cancer by combining ensemble regularized multinomial logistic regression and Cox regression.
Li J; Zhang H; Gao F
BMC Bioinformatics; 2022 Oct; 23(1):434. PubMed ID: 36258162
[TBL] [Abstract][Full Text] [Related]
7. Lobaplatin-based neoadjuvant chemotherapy for triple-negative breast cancer: a 5-year follow-up of a randomized, open-label, phase II trial.
Yan W; Wu X; Wang S; He C; Zhong L; Tang P; Ren L; Zhang T; Qi X; Zhang Y
Ther Adv Med Oncol; 2022; 14():17588359221107111. PubMed ID: 35769355
[TBL] [Abstract][Full Text] [Related]
8. Efficacy and Safety of Lobaplatin-TACE in the Treatment of Primary Hepatocellular Carcinoma: A Retrospective Study.
Lu H; Zheng C; Liang B; Xiong B
Anticancer Agents Med Chem; 2023; 23(4):461-469. PubMed ID: 35652401
[TBL] [Abstract][Full Text] [Related]
9. FBXW7 and the Hallmarks of Cancer: Underlying Mechanisms and Prospective Strategies.
Shen W; Zhou Q; Peng C; Li J; Yuan Q; Zhu H; Zhao M; Jiang X; Liu W; Ren C
Front Oncol; 2022; 12():880077. PubMed ID: 35515121
[TBL] [Abstract][Full Text] [Related]
10. MicroRNA-497-5p Functions as a Modulator of Apoptosis by Regulating Metadherin in Ovarian Cancer.
Liu C; Bordeaux A; Hettich S; Han S
Cell Transplant; 2020; 29():963689719897061. PubMed ID: 32046519
[TBL] [Abstract][Full Text] [Related]
11. The oncogene metadherin modulates the apoptotic pathway based on the tumor necrosis factor superfamily member TRAIL (Tumor Necrosis Factor-related Apoptosis-inducing Ligand) in breast cancer.
Zhang N; Wang X; Huo Q; Li X; Wang H; Schneider P; Hu G; Yang Q
J Biol Chem; 2013 Mar; 288(13):9396-407. PubMed ID: 23408429
[TBL] [Abstract][Full Text] [Related]
12. Lobaplatin inhibits growth of gastric cancer cells by inducing apoptosis.
Yin CY; Lin XL; Tian L; Ye M; Yang XY; Xiao XY
World J Gastroenterol; 2014 Dec; 20(46):17426-33. PubMed ID: 25516654
[TBL] [Abstract][Full Text] [Related]
13. Lobaplatin: a new antitumour platinum drug.
McKeage MJ
Expert Opin Investig Drugs; 2001 Jan; 10(1):119-28. PubMed ID: 11116285
[TBL] [Abstract][Full Text] [Related]
14. Pleiotropic roles of AEG-1/MTDH/LYRIC in breast cancer.
Wan L; Kang Y
Adv Cancer Res; 2013; 120():113-34. PubMed ID: 23889989
[TBL] [Abstract][Full Text] [Related]
15. Lobaplatin inhibits breast cancer progression, cell proliferation while it induces cell apoptosis by downregulating MTDH expression.
Tian W; Hao S; Gao B; Jiang Y; Zhang X; Zhang S; Guo L; Zhao J; Zhang G; Chen Y; Li Z; Luo D
Drug Des Devel Ther; 2018; 12():3563-3571. PubMed ID: 30464390
[TBL] [Abstract][Full Text] [Related]
16. Effect of combined treatment with lobaplatin and osthole on inducing apoptosis and inhibiting proliferation in human breast cancer MDA-MB-231 cells.
Liu N; Tian H; Zhang G; Sun N; Wang S
Med Oncol; 2021 Nov; 39(1):16. PubMed ID: 34837558
[TBL] [Abstract][Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
